Insulin reciprocally regulates glucagon secretion in humans

Diabetes

Volumn 59, Issue 11, 2010, Pages 2936-2940

  Cooperberg, Benjamin A ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN GLULISINE; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; MALE; YOUNG ADULT;

EID: 78049300087     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0728     Document Type: Article

References (43)

1. ATP-channels and glucose-regulated glucagon secretion. Trends Endocrinol Metab 2008;19:277-284
2. Samols E, Tyler J, Marks V. Glucagon-insulin interrelationships. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. Lefebvre P, Unger RH, Eds. Elmsford, NY, Pergamon Press, 1972, p. 151-174
3. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 1984;74:2296-2299
4. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocrine Reviews 2007;28:84-116 (Pubitemid 46220851)
5. Hauge-Evans AC, King AJ, Carmignac D, Richardson CC, Robinson IC, Low MJ, Christie MR, Persaud SJ, Jones PM. Somatostatin secreted by islet δ-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009;58:403-411
6. Taborsky GJ Jr, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia. Diabetes 1998;47:995-1005
7. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology 2007;22:241-251
8. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439
9. Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002;51:958-965 (Pubitemid 34438337)
10. Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 2005;28:1124-1131 (Pubitemid 40616623)
11. Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes. Diabetes Care 2005;28:2691-2696 (Pubitemid 43951161)
12. Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes. Diabetes 2005;54:757-764
13. Cooperberg BA, Cryer PE. β-Cell-mediated signaling predominates over direct α-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009;32:2275-2280
14. Bansal P, Wang Q. Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 2008;295:E751-E761
15. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB. Beta-cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 2005;54:1808-1815 (Pubitemid 40770771)
16. Galassetti P, Davis SN. Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clin Sci 2000;99:351-362
17. Zhou H, Zhang T, Harmon JS, Bryan J, Robertson RP. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 2007;56:1107-1112 (Pubitemid 46525066)
18. Brunicardi FC, Kleinman R, Moldovan S, Nguyen TH, Watt PC, Walsh J, Gingerich R. Immunoneutralization of somatostatin, insulin and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 2001;23:302-308 (Pubitemid 32910980)
19. Søndergaard LG, Stoltenberg M, Flyvbjerg A, Brock B, Schmitz O, Danscher G, Rungby J. Zinc ions in beta-cells of obese, insulin resistant, and type 2 diabetic rats traced by autometallography. APMIS 2003;111:1147-1154
20. Diao J, Asghar Z, Chan CB, Wheeler MB. Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem 2005;280:33487-33496
21. Xu E, Kumar M, Zhang Y, Ju W, Obata T, Zhang N, Liu S, Wendt A, Deng S, Ebina Y, Wheeler MB, Braun M, Wang Q. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006;3:47-58
22. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 1973;182:171-173
23. Polonsky K, Bergenstal R, Pons G, Schneider M, Jaspan J, Rubenstein A. Relation of counterregulatory responses to hypoglycemia in type I diabetics. N Engl J Med 1982;307:1106-1112 (Pubitemid 12030340)
24. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983;308:485-491
25. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Massi Benedetti M, Santeusanio F, Gerich JE, Brunetti P. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 1984;33:732-737 (Pubitemid 14053513)
26. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 1993;91:819-828
27. Bischof MG, Bernroider E, Ludwig C, Kurzemann S, Kletter K, Waldhäusl W, Roden M. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes. Horm Res 2001;56:151-158 (Pubitemid 34702072)
28. Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes. Diabetes 2003;52:1195-1203
29. Kishore P, Gabriely I, Cui MH, Di Vito J, Gajavelli S, Hwang JH, Shamoon H. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. Diabetes 2006;55:659-666
30. Wiethop BV, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993;16:1124-1130 (Pubitemid 23215400)
31. Caprio S, Tamborlane WV, Zych K, Gerow K, Sherwin RS. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM. Diabetes 1993;42:550-555 (Pubitemid 23097186)
32. Rossetti P, Porcellati F, Busciantella Ricci N, Candeloro P, Cioli P, Nair KS, Santeusanio F, Bolli GB, Fanelli CG. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes 2008;57:1905-1917
33. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977;26:22-29 (Pubitemid 8061860)
34. Shah SD, Clutter WE, Cryer PE. External and internal standards in the single isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med 1985;106:624-629
35. Lowry OH, Passoneau JV, Hasselberger FX, Schultz DW. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J Biol Chem 1964;239:18-30
36. Hosaka K, Kikuchi T, Mitsuhida N, Kawaguchi A. A new colorimetric method for the determination of free fatty acids with acyl-CoA synthase and acyl-CoA oxidase. J Biochem 1981;89:1799-1803 (Pubitemid 11048509)
37. Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993;42:1791-1798
38. Becker RHA. Insulin glulisine complementing basal insulins: a review of structure and activity. Diabetes Technol Ther 2007;9:109-121 (Pubitemid 46309714)
39. Pechhold K, Zhu X, Harrison VS, Lee J, Chakrabarty S, Koczwara K, Gavrilova O, Harlan DM. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes. Diabetes 2009;58:1175-1184
40. Dunning BE, Gerich JE. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 2007;28:253-283
41. Cherrington AD. Control of glucose production in vivo by insulin and glucagon. In Handbook of Physiology: The Endocrine Pancreas and Regulation of Metabolism. Sect. 7, vol. II. Cherrington AD, Jefferson LS, Eds. New York, Oxford University Press, 2001, pp 759-785
42. + channel mediates the zinc switch-off signal for glucagon response during glucose deprivation. Diabetes 2010;59:128-134
43. Quesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol 2008;199:5-19